GSK plc (GSK)

GSK Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,790	2,936	3,723	4,274	6,292	4,707
Short-Term Investments	1,305	2,246	4,154	61	78	79
Cash & Cash Equivalents	4,095	5,182	7,877	4,335	6,370	4,786
Cash Growth	-41.29%	-34.21%	81.71%	-31.95%	33.10%	20.92%
Receivables	6,831	7,385	7,053	7,860	6,952	7,202
Inventory	5,702	5,498	5,146	5,783	5,996	5,947
Other Current Assets	577	579	693	696	929	1,556
Total Current Assets	17,205	18,644	20,769	18,674	20,247	19,491
Property, Plant & Equipment	9,867	9,957	9,620	10,672	11,006	11,314
Long-Term Investments	1,277	1,192	1,541	2,214	3,424	2,151
Goodwill and Intangibles	22,645	21,579	21,364	40,631	40,421	41,517
Other Long-Term Assets	7,517	7,633	6,852	6,912	5,333	5,219
Total Long-Term Assets	41,306	40,361	39,377	60,429	60,184	60,201
Total Assets	58,511	59,005	60,146	79,103	80,431	79,692
Accounts Payable	14,621	15,844	16,263	17,554	15,840	14,939
Current Debt	2,616	2,813	3,952	3,601	3,725	6,918
Other Current Liabilities	2,609	2,411	2,595	2,515	2,583	2,193
Total Current Liabilities	19,846	21,068	22,810	23,670	22,148	24,050
Long-Term Debt	15,156	15,205	17,035	20,572	23,425	23,590
Other Long-Term Liabilities	10,280	9,937	10,205	13,519	14,050	13,695
Total Long-Term Liabilities	25,436	25,142	27,240	34,091	37,475	37,285
Total Liabilities	45,282	46,210	50,050	57,761	59,623	61,335
Total Debt	17,772	18,018	20,987	24,173	27,150	30,508
Debt Growth	-14.99%	-14.15%	-13.18%	-10.97%	-11.01%	17.05%
Retained Earnings	7,935	7,239	4,363	7,944	6,755	4,530
Shareholders' Equity	13,840	13,347	10,598	15,055	14,587	11,405
Net Cash / Debt	-13,677	-12,836	-13,110	-19,838	-20,780	-25,722
Working Capital	-2,641	-2,424	-2,041	-4,996	-1,901	-4,559
Book Value Per Share	6.82	6.58	5.26	7.51	7.31	5.74

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).